12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kogenate FS regulatory update

Bayer said it submitted on June 21 an sNDA to FDA for Kogenate FS for prophylaxis to reduce the frequency of...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >